Search Results - "Dionisio, Rossana"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2
  3. 3

    Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications by Valsecchi, Anna Amela, Ferrari, Giorgia, Paratore, Chiara, Dionisio, Rossana, Vignani, Francesca, Sperone, Paola, Vellani, Giorgio, Novello, Silvia, Di Maio, Massimo

    Published in Critical reviews in oncology/hematology (01-05-2024)
    “…In recent years, cancer research has highlighted the role of disrupted microbiota in carcinogenesis and cancer recurrence. However, microbiota may also…”
    Get full text
    Journal Article
  4. 4

    Clinical value of offering multiple chemotherapy lines to a luminal-like metastatic breast cancer: A case report with eribulin by Valsecchi, Anna Amela, Paparo, Jessica, Pirro, Valeria, Manfredi, Matteo, Di Maio, Massimo, Dionisio, Rossana

    Published in Tumori (01-12-2023)
    “…Introduction: The achievement of complete response with chemotherapy after multiple treatment lines in metastatic breast cancer and the chemosensitivity in a…”
    Get full text
    Journal Article
  5. 5

    Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer by Gamba, Teresa, Paparo, Jessica, Panepinto, Olimpia, Dionisio, Rossana, Di Maio, Massimo, Vignani, Francesca

    Published in Clinical genitourinary cancer (01-10-2023)
    “…Poly ADP-ribose polymerase inhibitors (PARPis) have clinical activity in several cancers. The rationale of their therapeutic use in urothelial cancer (UC)…”
    Get full text
    Journal Article
  6. 6

    Frequency of Germline and Somatic IBRCA1/I and IBRCA2/I Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis by Valsecchi, Anna Amela, Dionisio, Rossana, Panepinto, Olimpia, Paparo, Jessica, Palicelli, Andrea, Vignani, Francesca, Di Maio, Massimo

    Published in Cancers (01-04-2023)
    “…Our updated systematic review and meta-analysis investigates the frequency of germline and somatic BRCA1 and BRCA2 mutations in patients with prostate cancer…”
    Get full text
    Journal Article
  7. 7

    Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey by Valsecchi, Anna Amela, Fusco, Vittorio, Di Maio, Massimo, Santini, Daniele, Tucci, Marcello, De Giorgi, Ugo, Dionisio, Rossana, Vignani, Francesca, Cinieri, Saverio

    Published in Tumori (01-06-2024)
    “…Purpose: Cancer treatment–induced bone loss is a side effect of hormonal therapy that can severely affect patients' quality of life. The aim of this survey was…”
    Get full text
    Journal Article
  8. 8

    Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis by Valsecchi, Anna Amela, Dionisio, Rossana, Panepinto, Olimpia, Paparo, Jessica, Palicelli, Andrea, Vignani, Francesca, Di Maio, Massimo

    Published in Cancers (24-04-2023)
    “…In prostate cancer (PC), the presence of somatic and/or germline mutation provides prognostic and predictive information. Meta-analysis aims to estimate the…”
    Get full text
    Journal Article
  9. 9